{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:07:59Z","timestamp":1772824079344,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Sports University Project Grant","award":["XGYB202308"],"award-info":[{"award-number":["XGYB202308"]}]},{"name":"Guangzhou Sports University Project Grant","award":["XGYB202308"],"award-info":[{"award-number":["XGYB202308"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31201336)"],"award-info":[{"award-number":["31201336)"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88926-0","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:48:02Z","timestamp":1738586882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antihypertensive effect of sinapine extracted from rapeseed meal in 2K1C hypertensive rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Gaoyuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baomin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"88926_CR1","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/HYPERTENSIONAHA.121.17694","volume":"78","author":"S Correa","year":"2021","unstructured":"Correa, S., Guerra-Torres, X. E., Waikar, S. S. & Mc Causland, F. R. Serum magnesium, blood pressure, and risk of hypertension and chronic kidney Disease Progression in the CRIC Study. Hypertension 78, 1771\u20131780. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17694 (2021).","journal-title":"Hypertension"},{"key":"88926_CR2","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3390\/jcm9072265","volume":"9","author":"G Gallo","year":"2020","unstructured":"Gallo, G., Bianchi, F., Cotugno, M., Volpe, M. & Rubattu, S. Natriuretic peptides, cognitive impairment and dementia: an intriguing pathogenic link with implications in hypertension. J. Clin. Med. 9, 2265. https:\/\/doi.org\/10.3390\/jcm9072265 (2020).","journal-title":"J. Clin. Med."},{"key":"88926_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10654-019-00593-4","volume":"35","author":"H Pan","year":"2020","unstructured":"Pan, H., Hibino, M., Kobeissi, E. & Aune, D. Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies. Eur. J. Epidemiol. 35, 443\u2013454. https:\/\/doi.org\/10.1007\/s10654-019-00593-4 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"88926_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1161\/HYPERTENSIONAHA.120.15073","volume":"76","author":"RE Petrea","year":"2020","unstructured":"Petrea, R. E. et al. Mid to Late Life Hypertension trends and Cerebral Small Vessel Disease in the Framingham Heart Study. Hypertension 76, 707\u2013714. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15073 (2020).","journal-title":"Hypertension"},{"key":"88926_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/10641955.2020.1766489","volume":"39","author":"M Ghafarzadeh","year":"2020","unstructured":"Ghafarzadeh, M., Shakarami, A., Yari, F. & Namdari, P. The comparison of side effects of methyldopa, amlodipine, and metoprolol in pregnant women with chronic hypertension. Hypertens. Pregnancy. 39, 314\u2013318. https:\/\/doi.org\/10.1080\/10641955.2020.1766489 (2020).","journal-title":"Hypertens. Pregnancy"},{"key":"88926_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/cvr\/cvac110","volume":"119","author":"C Carnovale","year":"2023","unstructured":"Carnovale, C. et al. Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovasc. Res. 119, 647\u2013667. https:\/\/doi.org\/10.1093\/cvr\/cvac110 (2023).","journal-title":"Cardiovasc. Res."},{"key":"88926_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13659-020-00281-x","volume":"11","author":"T Verma","year":"2021","unstructured":"Verma, T. et al. Plants used as antihypertensive. Nat. Prod. Bioprospecting. 11, 155\u2013184 (2021).","journal-title":"Nat. Prod. Bioprospecting"},{"key":"88926_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.sajb.2020.09.008","volume":"135","author":"MZ Aumeeruddy","year":"2020","unstructured":"Aumeeruddy, M. Z. & Mahomoodally, M. F. Traditional herbal therapies for hypertension: a systematic review of global ethnobotanical field studies. South. Afr. J. Bot. 135, 451\u2013464 (2020).","journal-title":"South. Afr. J. Bot."},{"key":"88926_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.34172\/apb.2021.090","volume":"11","author":"R Kamyab","year":"2021","unstructured":"Kamyab, R. et al. Medicinal plants in the treatment of hypertension: a review. Adv. Pharm. Bull. 11, 601\u2013617. https:\/\/doi.org\/10.34172\/apb.2021.090 (2021).","journal-title":"Adv. Pharm. Bull."},{"key":"88926_CR10","doi-asserted-by":"publisher","first-page":"e08989","DOI":"10.1016\/j.heliyon.2022.e08989","volume":"8","author":"NJ Prado","year":"2022","unstructured":"Prado, N. J. et al. Anti-inflammatory, antioxidant, antihypertensive, and antiarrhythmic effect of indole-3-carbinol, a phytochemical derived from cruciferous vegetables. Heliyon 8, e08989. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e08989 (2022).","journal-title":"Heliyon"},{"key":"88926_CR11","doi-asserted-by":"publisher","first-page":"767975","DOI":"10.3389\/fphar.2021.767975","volume":"12","author":"EL Connolly","year":"2021","unstructured":"Connolly, E. L. et al. Glucosinolates from cruciferous vegetables and their potential role in chronic disease: investigating the preclinical and clinical evidence. Front. Pharmacol. 12, 767975 (2021).","journal-title":"Front. Pharmacol."},{"key":"88926_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/HJH.0000000000002021","volume":"37","author":"BM Egan","year":"2019","unstructured":"Egan, B. M., Kjeldsen, S. E., Grassi, G., Esler, M. & Mancia, G. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J. Hypertens. 37, 1148\u20131153 (2019).","journal-title":"J. Hypertens."},{"key":"88926_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","volume":"79","author":"A Al-Makki","year":"2022","unstructured":"Al-Makki, A. et al. Hypertension pharmacological treatment in adults: a World Health Organization Guideline Executive Summary. Hypertension 79, 293\u2013301. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18192 (2022).","journal-title":"Hypertension"},{"key":"88926_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/foods12030520","volume":"12","author":"M Chadni","year":"2023","unstructured":"Chadni, M. et al. Improvement of sinapine extraction from mustard seed meal by application of emerging technologies. Foods 12, 520 (2023).","journal-title":"Foods"},{"key":"88926_CR15","doi-asserted-by":"crossref","unstructured":"Yu, P., Ma, Z., Jiang, H., Liu, J. & Li, H. Sinapine thiocyanate alleviates intervertebral disc degeneration by not regulating JAK1\/STAT3\/NLRP3 signal pathway. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University (2024).","DOI":"10.17219\/acem\/174508"},{"key":"88926_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1134\/S002689332005012X","volume":"54","author":"Z Yang","year":"2020","unstructured":"Yang, Z. et al. Extraction and separation of sinapine from rapeseed cake and the mode of action of melanin production inhibition. Mol. Biol. 54, 911\u2013918 (2020).","journal-title":"Mol. Biol."},{"key":"88926_CR17","first-page":"379","volume":"30","author":"D Yun","year":"2013","unstructured":"Yun, D. et al. Preparation and hypotensive effect of sinapine chloride in spontaneous hypertension rats. J. Shenyang Pharm. Univ. 30, 379\u2013382 (2013).","journal-title":"J. Shenyang Pharm. Univ."},{"key":"88926_CR18","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1139\/Y09-089","volume":"87","author":"YH Gomez Sandoval","year":"2009","unstructured":"Gomez Sandoval, Y. H., Levesque, L. O. & Anand-Srivastava, M. B. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 87, 1037\u20131045. https:\/\/doi.org\/10.1139\/Y09-089 (2009).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"88926_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/s0008-6363(97)00156-9","volume":"36","author":"RS Rao","year":"1997","unstructured":"Rao, R. S., Miano, J. M., Olson, E. N. & Seidel, C. L. The A10 cell line: a model for neonatal, neointimal, or differentiated vascular smooth muscle cells? Cardiovasc. Res. 36, 118\u2013126. https:\/\/doi.org\/10.1016\/s0008-6363(97)00156-9 (1997).","journal-title":"Cardiovasc. Res."},{"key":"88926_CR20","doi-asserted-by":"publisher","first-page":"H1543","DOI":"10.1152\/ajpheart.00683.2020","volume":"320","author":"V Truong","year":"2021","unstructured":"Truong, V., Jain, A., Anand-Srivastava, M. B. & Srivastava, A. K. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 320, H1543\u2013H1554. https:\/\/doi.org\/10.1152\/ajpheart.00683.2020 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"88926_CR21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1139\/cjpp-2017-0127","volume":"95","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Effect of lysophosphatidylglycerol on intracellular free ca(2+) concentration in A10 vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 95, 1283\u20131288. https:\/\/doi.org\/10.1139\/cjpp-2017-0127 (2017).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"88926_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/10641963.2021.1945077","volume":"43","author":"X He","year":"2021","unstructured":"He, X. et al. The potential role of RAAS-related hsa_circ_0122153 and hsa_circ_0025088 in essential hypertension. Clin. Exp. Hypertens. 43, 715\u2013722. https:\/\/doi.org\/10.1080\/10641963.2021.1945077 (2021).","journal-title":"Clin. Exp. Hypertens."},{"key":"88926_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1060028018779082","volume":"52","author":"A Helmer","year":"2018","unstructured":"Helmer, A., Slater, N. & Smithgall, S. A. Review of ACE inhibitors and ARBs in black patients with hypertension. Ann. Pharmacother. 52, 1143\u20131151. https:\/\/doi.org\/10.1177\/1060028018779082 (2018).","journal-title":"Ann. Pharmacother"},{"key":"88926_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/HYPERTENSIONAHA.119.14315","volume":"76","author":"Z Li","year":"2020","unstructured":"Li, Z., Lindner, D. P., Bishop, N. M. & Cipolla, M. J. ACE (angiotensin-Converting enzyme) inhibition reverses vasoconstriction and impaired dilation of Pial collaterals in Chronic Hypertension. Hypertension 76, 226\u2013235. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14315 (2020).","journal-title":"Hypertension"},{"key":"88926_CR25","doi-asserted-by":"publisher","first-page":"170171","DOI":"10.1016\/j.peptides.2019.170171","volume":"122","author":"B Qian","year":"2019","unstructured":"Qian, B. et al. Design and evaluation of four novel tripeptides as potent angiotensin converting enzyme (ACE) inhibitors with anti-hypertension activity. Peptides 122, 170171 (2019).","journal-title":"Peptides"},{"key":"88926_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/HJH.0000000000002379","volume":"38","author":"A Battistoni","year":"2020","unstructured":"Battistoni, A. et al. Antihypertensive drugs and the risk of cancer: a critical review of available evidence and perspective. J. Hypertens. 38, 1005\u20131015. https:\/\/doi.org\/10.1097\/HJH.0000000000002379 (2020).","journal-title":"J. Hypertens."},{"key":"88926_CR27","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.injury.2021.09.036","volume":"53","author":"DWG Langerhuizen","year":"2022","unstructured":"Langerhuizen, D. W. G., Verweij, L. P. E., van der Wouden, J. C., Kerkhoffs, G. & Janssen, S. J. Antihypertensive drugs demonstrate varying levels of hip fracture risk: a systematic review and meta-analysis. Injury 53, 1098\u20131107. https:\/\/doi.org\/10.1016\/j.injury.2021.09.036 (2022).","journal-title":"Injury"},{"key":"88926_CR28","doi-asserted-by":"publisher","first-page":"602985","DOI":"10.3389\/fphar.2020.602985","volume":"11","author":"LF Alawi","year":"2020","unstructured":"Alawi, L. F. et al. Effects of Angiotensin II type 1A receptor on ACE2, Neprilysin and KIM-1 in two kidney one clip (2K1C) model of Renovascular Hypertension. Front. Pharmacol. 11, 602985. https:\/\/doi.org\/10.3389\/fphar.2020.602985 (2020).","journal-title":"Front. Pharmacol."},{"key":"88926_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/ph15070853","volume":"15","author":"KGT Moreno","year":"2022","unstructured":"Moreno, K. G. T. et al. A New Approach for the development of multiple Cardiovascular risk factors in two rat models of hypertension. Pharmaceuticals (Basel). 15, 853. https:\/\/doi.org\/10.3390\/ph15070853 (2022).","journal-title":"Pharmaceuticals (Basel)"},{"key":"88926_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41440-021-00643-z","volume":"44","author":"T Ghatage","year":"2021","unstructured":"Ghatage, T., Goyal, S. G., Dhar, A. & Bhat, A. Novel therapeutics for the treatment of hypertension and its associated complications: peptide- and nonpeptide-based strategies. Hypertens. Res. 44, 740\u2013755. https:\/\/doi.org\/10.1038\/s41440-021-00643-z (2021).","journal-title":"Hypertens. Res."},{"key":"88926_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","volume":"40","author":"S Beyerstedt","year":"2021","unstructured":"Beyerstedt, S., Casaro, E. B. & Rangel, E. B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 40, 905\u2013919. https:\/\/doi.org\/10.1007\/s10096-020-04138-6 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"88926_CR32","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1016\/j.sjbs.2021.07.003","volume":"28","author":"A Elshafei","year":"2021","unstructured":"Elshafei, A., Khidr, E. G., El-Husseiny, A. A. & Gomaa, M. H. RAAS, ACE2 and COVID-19; a mechanistic review. Saudi J. Biol. Sci. 28, 6465\u20136470. https:\/\/doi.org\/10.1016\/j.sjbs.2021.07.003 (2021).","journal-title":"Saudi J. Biol. Sci."},{"key":"88926_CR33","doi-asserted-by":"publisher","first-page":"770375","DOI":"10.3389\/fphys.2022.770375","volume":"13","author":"A Tsilosani","year":"2022","unstructured":"Tsilosani, A., Gao, C. & Zhang, W. Aldosterone-Regulated Sodium Transport and Blood pressure. Front. Physiol. 13, 770375. https:\/\/doi.org\/10.3389\/fphys.2022.770375 (2022).","journal-title":"Front. Physiol."},{"key":"88926_CR34","doi-asserted-by":"publisher","first-page":"CD012569","DOI":"10.1002\/14651858.CD012569.pub2","volume":"10","author":"GM Wang","year":"2020","unstructured":"Wang, G. M., Li, L. J., Tang, W. L. & Wright, J. M. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database Syst. Rev. 10, CD012569. https:\/\/doi.org\/10.1002\/14651858.CD012569.pub2 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"88926_CR35","doi-asserted-by":"publisher","first-page":"e26544","DOI":"10.1097\/MD.0000000000026544","volume":"100","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: an updated meta-analysis of randomized controlled trials. Med. (Baltim). 100, e26544. https:\/\/doi.org\/10.1097\/MD.0000000000026544 (2021).","journal-title":"Med. (Baltim)."},{"key":"88926_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.drudis.2021.03.001","volume":"26","author":"X 36 Feng","year":"2021","unstructured":"36 Feng, X. et al. New views on endothelial dysfunction in gestational hypertension and potential therapy targets. Drug Discov Today. 26, 1420\u20131436. https:\/\/doi.org\/10.1016\/j.drudis.2021.03.001 (2021).","journal-title":"Drug Discov Today"},{"key":"88926_CR37","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/life11090986","volume":"11","author":"K Kostov","year":"2021","unstructured":"Kostov, K. The causal relationship between endothelin-1 and hypertension: focusing on endothelial dysfunction, arterial stiffness, vascular remodeling, and blood pressure regulation. Life 11, 986 (2021).","journal-title":"Life"},{"key":"88926_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00467-021-05144-2","volume":"37","author":"S Genovesi","year":"2022","unstructured":"Genovesi, S. et al. Relationship between endothelin and nitric oxide pathways in the onset and maintenance of hypertension in children and adolescents. Pediatr. Nephrol. 37, 537\u2013545 (2022).","journal-title":"Pediatr. Nephrol."},{"key":"88926_CR39","doi-asserted-by":"publisher","first-page":"e19822","DOI":"10.7759\/cureus.19822","volume":"13","author":"RN Chakraborty","year":"2021","unstructured":"Chakraborty, R. N., Langade, D., More, S., Revandkar, V. & Birla, A. Efficacy of Cilnidipine (L\/N-type Calcium Channel Blocker) in treatment of hypertension: a Meta-analysis of Randomized and non-randomized controlled trials. Cureus 13, e19822. https:\/\/doi.org\/10.7759\/cureus.19822 (2021).","journal-title":"Cureus"},{"key":"88926_CR40","doi-asserted-by":"publisher","first-page":"e27847","DOI":"10.7759\/cureus.27847","volume":"14","author":"M Srivathsan","year":"2022","unstructured":"Srivathsan, M. et al. Renal function in hypertensive patients receiving cilnidipine and L-Type Calcium Channel blockers: a Meta-analysis of Randomized Controlled and Retrospective studies. Cureus 14, e27847. https:\/\/doi.org\/10.7759\/cureus.27847 (2022).","journal-title":"Cureus"},{"key":"88926_CR41","first-page":"395","volume":"61","author":"MV Melnik","year":"2016","unstructured":"Melnik, M. V., Afonicheva, I. I. & Beloborodova, A. V. [the Role Pleiotropic effects of Calcium Channel Blocker Lercanidipine in Perioperative Therapy of arterial hypertension]. Anesteziol. Reanimatol. 61, 395\u2013398 (2016).","journal-title":"Anesteziol. Reanimatol"},{"key":"88926_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1074248414530508","volume":"19","author":"T Godfraind","year":"2014","unstructured":"Godfraind, T. Calcium channel blockers in cardiovascular pharmacotherapy. J. Cardiovasc. Pharmacol. Ther. 19, 501\u2013515. https:\/\/doi.org\/10.1177\/1074248414530508 (2014).","journal-title":"J. Cardiovasc. Pharmacol. Ther."}],"updated-by":[{"DOI":"10.1038\/s41598-025-20197-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88926-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:04:02Z","timestamp":1758575042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88926"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88926-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-20197-1","URL":"https:\/\/doi.org\/10.1038\/s41598-025-20197-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments in this study were performed in accordance with the UK Animals (Scientific Procedures) Act (1986) and ARRIVE guidelines, and the Institutional Animal Care and Use Committee of DALIAN University approved all procedures performed on animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"4133"}}